DrugsControl Media Services

News Detail

NPPA invokes Para 3 of DPCO to direct Macleods Pharma to supply anti-TB drug to CMSS (15-06-2024)

New Delhi, 15 June 2024: The National Pharmaceutical Pricing Authority (NPPA) has  invoked the Para 3 of the Drugs (Prices Control) Order, 2013, and directed Mumbai-based Macleods Pharmaceuticals to supply anti-tuberculosis drug rifampicin 150 mg and 450 mg capsules to the c......
View Details

Source : Pharmabiz
NPPA Para 3 Drugs (Prices Control) Order Macleods Pharmaceuticals anti-tuberculosis drug rifampicin Central Medical Services Society CMSS DPCO 2013 API bulk drug National Tuberculosis Elimination Programme NTEP Lok Sabha

Related News